## ROL: Rollins, Inc. - XLY: Consumer Cyclical

### Executive Summary

No thesis match: MRS_20 -0.1% below STRENGTH zone (4.0-10.0%); PEG 3.96 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge. Caution: declining volume (59% of avg), momentum weakening (-3.7% MRS).

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($58.58)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_20 falling below -5% or breaking key support

### News

- **Articles:** 10
- **Sentiment:** Bullish (Bullish: 6, Bearish: 0)

**1. Bernstein reiterates Outperform rating on Rollins stock at $70 price target**
- Source: Investing.com | 20251202T081700 | Bullish | Relevance: 100%
- Bernstein has reiterated its Outperform rating on Rollins (NYSE:ROL) with a $70 price target, highlighting the company as a top pick among waste companies despite its premium valuation. The firm noted CFO Ken Krause's unrecognized background in cost reduction as a key factor and addressed investor discussions around the Rollins family's share sale and Rentokil's potential turnaround. Rollins' stock has shown strong returns year-to-date and is trading near its 52-week high, reflecting continued investor confidence amidst ongoing leadership changes and modernization efforts.

**2. Bernstein reiterates Outperform rating on Rollins stock at $70 price target**
- Source: Investing.com | 20251202T081700 | Bullish | Relevance: 100%
- Bernstein has reiterated its Outperform rating and a $70.00 price target on Rollins (NYSE:ROL), considering it a top pick among waste companies despite its premium valuation. The firm highlights CFO Ken Krause's cost-cutting expertise from his previous role and observes strong YTD stock returns. Investor discussions also covered a recent share sale by the Rollins family as well as potential shifts with competitor Rentokil.

**3. Rollins To Host 2025 Sell-Side Analyst Conference at the New York Stock Exchange on December 9th**
- Source: KSNT 27 News | 20251201T161800 | Somewhat-Bullish | Relevance: 100%
- Rollins, Inc. (NYSE: ROL) will host a 2025 Sell-Side Analyst Conference on Tuesday, December 9th at 9 a.m. Eastern Time at the New York Stock Exchange. CEO Jerry Gahlhoff and CFO Ken Krause, along with other leadership team members, will discuss strategic initiatives and future value creation. The event will be webcast live, with a replay available for 180 days.

**4. Rollins (NYSE: ROL) sets Dec. 9, 2025 NYSE sell-side analyst event webcast details**
- Source: Stock Titan | 20251201T161800 | Neutral | Relevance: 100%
- Rollins (NYSE: ROL) announced it will host a 2025 Sell-Side Analyst Conference at the New York Stock Exchange on Tuesday, December 9, 2025, at 9:00 a.m. ET. CEO Jerry Gahlhoff and CFO Ken Krause, along with other leaders, will discuss strategic initiatives and future value creation. The event will be webcast live, and a replay will be available for 180 days.

**5. Mackenzie Financial Corp Increases Position in Rollins, Inc. $ROL**
- Source: MarketBeat | 20251202T115150 | Bullish | Relevance: 100%
- Mackenzie Financial Corp increased its stake in Rollins, Inc. (NYSE: ROL) by 10.8%, bringing its total holdings to 954,142 shares valued at $53.8 million. This increase contributes to institutional investors owning approximately 51.8% of the company. Rollins recently reported strong quarterly earnings, beating analyst expectations with $0.35 EPS and $1.03 billion in revenue, and subsequently boosted its quarterly dividend.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 0, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-11-12 | Bernstein | $70 | $0 | 0% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-11-12 | Bernstein | init | Outperform |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 0 ($0.00M) |
| Sells | 7 ($3296.08M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 24.4% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 5 / 4 |

**Top Holders:**
- Vanguard Group Inc: 7.6% (+4.2%)
- Blackrock Inc.: 6.0% (+1.2%)
- State Street Corpora: 2.5% (+1.4%)
- Kayne Anderson Rudni: 2.0% (-2.8%)
- Geode Capital Manage: 2.0% (+1.7%)

### Key Risks

1. Heavy insider selling: $3296M sold (7 transactions in 90 days).
2. Valuation stretched: PEG 4.0x requires aggressive growth execution.
3. Market regime shift could impact momentum names disproportionately.

### Catalysts

- AI/machine learning initiatives could drive multiple expansion if executed.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 3.96 signals overvaluation risk, limited margin of safety. Forward P/E 47.4x stretched relative to 12% growth. Quality metrics strong (ROE 36%, ROA 15%). Insider selling cluster ($3296.1M in 90 days), potential headwind. Institutional flow bullish (5 buying vs 4 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $29.2B |
| Beta | 0.79 |
| 52W Range | $45.34 - $61.84 |
| Short Interest | 3.2% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 3.96 |
| Forward P/E | 47.4 |
| Current P/E | 53.1 |
| YoY Growth | 12.1% |
| EPS Direction | STABLE |

### Technicals

MRS_20 deteriorating from 3.6% to -0.1% (-3.7% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 4.1pp (needs >4.0% for momentum thesis). Full SMA alignment bullish (above 20/50/200 SMAs). Volume at 59% of 20MA suggests lack of conviction. OFD pattern: -MTL (Decline).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | -0.08% (CS: 51) | Neutral |
| RSI_14 | 60.5 | Neutral |
| MACD Histogram | 0.11 | Bullish |
| vs SMA20 | 1.018x | Above |
| vs SMA50 | 1.043x | Above |
| vs SMA200 | 1.079x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $60.62
- **Stop Loss:** $58.58 (3.4% risk)
- **Target:** $62.66 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 558
- **Position Value:** $33,825.96
- **Portfolio %:** 33.83%
- **Risk Dollars:** $1,140.00
- **Risk Per Trade:** 1.14%
- **Modifiers:** L1 95% | L2 120% | Combined 1.14x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 0.95x |
| L2 Sector | TREND (Zone A) | 1.20x |

*NORMAL regime with moderately constructive conditions. Fed dovish pivot expectations from weak jobs data and declining VIX suggest improving risk appetite, though narrow breadth at 51% indicates selective participation. Focus on quality sectors benefiting from rate cut expectations.*

### Earnings

**Next:** 2026-02-18 (Est: $0.27)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $0.33 | $0.35 | +6.3% |
| 2025Q2 | $0.30 | $0.30 | -0.7% |
| 2025Q1 | $0.22 | $0.22 | +1.3% |
| 2024Q4 | $0.23 | $0.23 | -0.8% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_20*